LABD vs SDS

Direxion Daily S&P Biotech Bear 3X ETF against ProShares UltraShort S&P500: cost, size, returns, what they hold and how much of it is the same.

Fee gap
16 bp
SDS is cheaper
1-year return gap
53.0 pts
SDS is ahead
Larger fund
SDS
$405M

Side by side

LABDSDS
FundDirexion Daily S&P Biotech Bear 3X ETFProShares UltraShort S&P500
IssuerDirexionProShares
CategoryInverse EquityInverse Equity
Expense ratio1.07%0.91%
Assets$79M$405M
Average daily dollar volume$191M$259M
ListedMay 28, 2015Jul 11, 2006
FrenzyCap score5477
1-month return−7.8%+4.5%
3-month return+1.9%+4.3%
Year to date−64.8%−18.5%
1-year return−72.3%−19.3%
30-day volatility117.9%37.5%
Worst drawdown, 1 year−79.1%−34.5%
Trailing 12-month yield6.20%5.07%
Holdings1026
Top 10 weight0.0%37.5%
Look-through P/E——
Holdings vs fair value——
Holdings above 200-day average——
Net flow, latest 3 reported months+$16M thru Jul 2026−$48M thru Aug 2026
30-day implied volatility98.7%31.0%
Holdings as ofas of Nov 13, 2026issuer dataas of Nov 13, 2026issuer data

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

More: full overlap table · LABD holdings · SDS holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.